The polymerase chain reaction (PCR) was used to detect Mycobacterium tuberculosis DNA in 29 CSF specimens from seven patients with tuberculous meningitis after the start of antituberculous chemotherapy. Ten of the 13 CSF specimens taken from these patients with an initial treatment of three weeks were positive for the PCR study. By contrast, only one of the other 16 CSF specimens taken from patients treated for more than three weeks was positive. This study shows that M tuberculosis DNA can exist in the CSF of a patient with tuberculous meningitis for three weeks after treatment and that PCR can still be a sensitive method to detect M tuberculosis DNA in the CSF after the start of treatment in patients with tuberculous meningitis.
Abstract
The polymerase chain reaction (PCR) was used to detect Mycobacterium tuberculosis DNA in 29 CSF specimens from seven patients with tuberculous meningitis after the start of antituberculous chemotherapy. Ten of the 13 CSF specimens taken from these patients with an initial treatment of three weeks were positive for the PCR study. By contrast, only one of the other 16 CSF specimens taken from patients treated for more than three weeks was positive. This study shows that M tuberculosis DNA can exist in the CSF of a patient with tuberculous meningitis for three weeks after treat years, four patients with complete resolution and two with residual mild neurological deficits. One was in a vegetative state.
Discussion
The PCR has been used to define novel diagnostic and epidemiological data for neurological diseases based on the fact that the method is rapid, accurate, and non-invasive.9 For identification of mycobacterial DNA in CSF specimens, PCR has proved to be the most sensitive method for an accurate diagnosis of tuberculous meningitis.'-8 Nevertheless, PCR assay has problems, especially when dealing with samples containing small amounts of mycobacterial bacilli. The study of Hance et al showed that when using hybridisation with a 32P-labelled oligonucleotide, the sensitivity of the application of PCR for detection of M tuberculosis DNA in clinical specimens could be improved.'01' Some studies showed that a nested PCR protocol could also improve the sensitivity of detecting mycobacterial DNA in clinical specimens.6 1213 The study of Ostergaard et al, however, showed that Southern hybridisation on the nested PCR product did not give further PCR positive results.'4 Therefore, regarding sensitivity, the nested PCR is superior to Southern hybridisation for the detection of M tuberculosis DNA in CSF specimens, due to fact that nested PCR is simpler and less time consuming. Because the detection of mycobacterial DNA in our previous report was done by PCR after Southern hybridisation,8 we therefore still used the same method in this study to have the advantage of a comparison between the sensitivity of PCR in detecting M tuberculosis DNA in the CSF of patients with tuberculous meningitis before and after antituberculous treatment.
After the start of treatment, mycobacterial cultures of CSF in patients with tuberculous meningitis rarely yield a positive result, '5 which was the same as found in our study. Yet our study showed that PCR could persistently detect M tuberculosis DNA in the CSF of patients with tuberculous meningitis within the initial three week treatment period. After treatment for more than three weeks, the PCR rarely yielded a positive result. Because treatment was effective in this study (as shown by radiology and the resolution of clinical symptoms), the persistent presence of M tuberculosis DNA in CSF may indicate that antituberculous treatment induces the release of mycobacterial DNA in CSF. This persistence of positive PCR results was also found in patients with neurosyphilis in whom Treponema pallidum DNA was detectable in the CSF several months after effective treatment'8 and patients with cerebral toxoplasmosis in whom Toxoplasma gondii in the blood could also be detected for up to 12 days after initiation of treatment. '9 When compared with our previous report,8 this study does not indicate a significant difference of PCR sensitivity for applying the method to detect M tuberculosis DNA in the CSF of patients with tuberculous meningitis before treatment (70% of sensitivity) and after an initial treatment of three weeks (78% of sensitivity). The sensitivity of applying PCR to detect M tuberculosis DNA in the CSF of patients with tuberculous meningitis having the initial treatment for three weeks is also similar to that of other studies.3-8 Therefore, we advise that it is still valuable to apply PCR in patients with clinically suspected tuberculous meningitis who promptly receive a diagnostic antituberculous trial.
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